If you are having trouble viewing this email, please view it on our website.

     
 
   
   
 
Hi

Are you ready for the patient-centered clinical trial? What steps have you taken? That's at the heart of what we asked some of the leading innovators in the clinical research industry for our new whitepaper.

Download the paper here: "Patient-Focused Drug Development - Fact, or Fiction?"

With individual, personalized, and patient-centric medicine on the horizon, sponsor companies are reconsidering their approach to clinical trials. Patient-centered drug development has become a hot-button issue. The white paper features:
  • Exclusive insights from leading pharma, incl. Eli Lilly, Pfizer, Novartis, Genentech, Shire, Janssen/ J&J on how to make patient-centricity a workable model in drug development
  • A guide on how to place data generation in the hands of patients, including a step-by-step reflection on how to achieve the benefits of ePRO
  • Five, research-based steps that can help boost patient engagement in clinical trials with the existing site model and beyond.
Click here to download your free copy of the 20-page paper.

What’s your take - how far has the industry come in putting patients at the center of clinical trials?

Best,

Ulrich B. Neumann
Head of Patient-Centered Clinical Trial Initiative
Director, eyeforpharma
ulrich@eyeforpharma.com
T: 201-204-1688

eyeforpharma is a hub for senior-level pharma executives, patient advocacy groups and other health experts to exchange ideas and stay up to date with shifting trends and practices within the pharmaceutical industry. We provide industry-focused commentary, events, reports, and other valuable expert-driven content. Our ultimate aim is to facilitate positive change through discussion and debate, enabling dialogue within the industry and driving the positive benefits that pharmaceuticals can offer. We actively respond to the aims and interests of our audience, so please get in touch if you think we can do even more. eyeforpharma is part of FC Business Intelligence Ltd. FC Business Intelligence Ltd is a registered company in England and Wales - Registered number 04388971, 7-9 Fashion Street, London, E1 6PX, UK.
 
ACT is published by Advanstar Communications, 485 Rt 1 South, Iselin, NJ 08830.